Description
Level of education: Master's degree (level 7 EQF/CEC and CNC)
Fundamental field: Biological and biomedical sciences
Study field: Pharmacy
Study program: Drugs from use to abuse. Pharmacovigilance and regulation
Qualification: Pharmacovigilance Research Assistant
The objective of the Drugs from use to abuse. Pharmacovigilance and regulation Master's degree program is the training of specialists in the field of pharmacovigilance and clinical trials involving drugs, specialists who will improve the medical system through active involvement in monitoring the efficacy and safety of pharmacotherapy, critical assessment of drug intoxications, identification and reporting of adverse reactions, development of substance misuse reduction plans and optimization of therapy on pharmacokinetic, clinical and paraclinical criteria. Professional training will be provided by specialists in the fields of pharmacology, toxicology, laboratory analysis and related areas of applicable legislation (law).
Starting with the academic year 2023-2024, the master's students, supported by Astra Zeneca, will have the opportunity to carry out a practical training at the Pharmacovigilance Centre of Excellence in Târgu Mureș.
Who is it for?
- Graduates of the Faculty of Medicine
- Graduates of the Faculty of Pharmacy
- Specialists coming from a socio-economic background (pharmaceutical industry, regulatory and control authorities for medicinal products and food supplements) who can justify basic knowledge in the specialties covered by the Master's degree.
Occupational prospects
- Pharmaceutical Industry
- Pharmacovigilance Specialist
- Monitors and evaluates adverse drug reactions, reporting them to regulatory authorities;
- Ensures compliance with regulatory requirements and manages drug-related risks;
- Contributes to the development and implementation of risk minimization strategies.
- Pharmacovigilance Data Analyst
- Works with databases to identify safety signals and trends.
- Regulatory and Public Health Institutions
- Analyzes drug safety data and ensures regulatory compliance for medicinal products.
- Research and Development
- Pharmacoepidemiology Researcher
- studies the use and effects of medications in large populations.
- Pharmacovigilance Consultant
- advises pharmaceutical companies and institutions on drug safety strategies.
General information
Duration
2 years (4 semesters); 120 ECTS
Study Format
Full-time
Study language
Romanian
ARACIS Status
Accredited
Program coordinator
Professor Camil-Eugen Vari, PhD
e-mail: camil.vari@umfst.ro